{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:01:39Z","timestamp":1746417699757,"version":"3.40.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shandong Natural Foundation","award":["ZR2019MH111"],"award-info":[{"award-number":["ZR2019MH111"]}]},{"name":"Shandong Natural Foundation","award":["ZR2017MH021"],"award-info":[{"award-number":["ZR2017MH021"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Central retinal vein occlusion (CRVO) is one of the most common retinal vascular diseases, which is closely related to systemic diseases like hypertension, diabetes and arteriosclerosis. Due of its blinding, it will seriously reduce the quality of life. Macular edema (ME) caused by CRVO is one of the serious complications of visual impairment. We found that the severity of ME in CRVO was positively associated with vascular endothelial growth factor (VEGF) in the anterior chamber. With the accelerated pace of modern life and the changed dietary structure, the incidence of this disease will continue to rise. Therefore, it is of great practical significance to seek effective treatment methods. Intraocular injection of anti-VEGF can effectively alleviate ME and improve visual acuity, showing excellent clinical application prospects. In recent years, there have been some new understandings and advances on the etiology and treatment methods of the present disease, such as the deepening into the molecular biology and gene level. Clinical studies on the efficacy of the disease have emerging. Therefore, a network meta-analysis (NMA) of anti-VEGF treatment for CRVO is particularly necessary to systematically compare its efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The two reviewers will comprehensively retrieved electronic databases such as PubMed, The Cochrane Library, Wanfang database, Web of Science, Chinese Scientifific Journals Database, EMBASE, China National Knowledge Infrastructure, and China BioMedical Literature. A randomized controlled trial for CRVO against VEGF between January 2010 and June 2021 was included according to the relevant content of the study. In addition, 2 researchers will screen the literature to assess the risk bias for the included articles. We will evaluate the collected evidence and data using a Bayesian NMA method, and analyzed it with STATA and WinBUGS software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Anti-VEGF is one of the effective methods for ME in CRVO patients, accordingly, this study will evaluate its efficacy and safety using a Bayesian NMA system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study can provide an effective rationale for the clinical application of anti-VEGF for CRVO, contribute to the treatment of CRVO and patient condition rehabilitation in clinical work.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>Do not require.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INPLASY registration number:<\/jats:title>\n            <jats:p>INPLASY2021110073.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028283","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T15:36:22Z","timestamp":1640878582000},"page":"e28283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparative efficacy and safety of antivascular endothelial growth factors for central retinal vein occlusion"],"prefix":"10.1097","volume":"100","author":[{"given":"Zhigao","family":"Liu","sequence":"first","affiliation":[{"name":"First Clinical Medical college, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Wang","sequence":"additional","affiliation":[{"name":"First Clinical Medical college, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-5268","authenticated-orcid":false,"given":"Bojun","family":"Zhao","sequence":"additional","affiliation":[{"name":"First Clinical Medical college, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"},{"name":"Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/08820538.2021.1890147","article-title":"Twenty-four month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion: visual outcomes and resolution of macular edema","volume":"36","author":"Inagaki","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4103\/ijo.IJO_1644_21","article-title":"Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic \u2013 a case report","volume":"69","author":"Sarpangala","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00417-020-04983-3","article-title":"Choroidal thickening in retinal vein occlusion patients with serous retinal detachment","volume":"259","author":"Lulu","year":"2021","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"R4-20250504","article-title":"Central retinal arterial and venous occlusion in a patient with systemic sclerosis and a review of the related literature","volume":"9","author":"Aya","year":"2021","journal-title":"Am J Int Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2021.01.027","article-title":"Efficacy and safety of intravitreal aflibercept treat-and-extend for macular edema in central retinal vein occlusion: the CENTERA study","volume":"227","author":"Jean-Fran\u00e7ois","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12886-020-01702-8","article-title":"Central retinal artery and vein occlusion as a complication of persistent hyaloid artery \u2013 a case report","volume":"20","author":"Bjelo\u0161","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/ijo.IJO_3223_20","article-title":"A curious case of macular edema in persistent fetal vasculature","volume":"1","author":"Chakraborty","year":"2021","journal-title":"Indian J Ophthalmol \u2013 Case Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/2474126420978874","article-title":"Treatment patterns and clinical outcomes for branch retinal vein occlusion: an 8-year experience at a tertiary eye center","volume":"5","author":"Lee","year":"2021","journal-title":"J Vitreoretinal Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcjo.2020.09.004","article-title":"Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion","volume":"56","author":"Dewan","year":"2021","journal-title":"Can J Ophthalmol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"4529850","DOI":"10.1155\/2020\/4529850","article-title":"Effects of switching from Anti-VEGF treatment to triamcinolone acetonide in eyes with refractory macular edema associated with diabetic retinopathy or retinal vein occlusion","volume":"2020","author":"Tatsumi","year":"2020","journal-title":"BioMed Res Int"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbrc.2018.12.049","article-title":"The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion","volume":"508","author":"Xia","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"Approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10103-020-03133-9","article-title":"Closure of macular hole secondary to ischemic hemi-central retinal vein occlusion by retinal photocoagulation and topical anti-inflammatory treatment","volume":"36","author":"Teru Asato","year":"2021","journal-title":"Lasers Med Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13167-021-00233-6","article-title":"Optical coherence tomographic patterns in patients with retinal vein occlusion and macular edema treated by ranibizumab: a predictive and personalized approach","volume":"12","author":"D Khokhlova","year":"2021","journal-title":"EPMA J"},{"key":"R16-20250504","first-page":"e7","article-title":"Neovascular glaucoma in patients with central retinal vein occlusion: A real-life study in the anti-VEGF era","volume":"99","author":"Casselholm de","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.3928\/23258160-20190401-13","article-title":"Intravitreal anti-vascular endothelial growth factor injections for macular edema associated with central retinal vein occlusion in patients age 40 years or younger","volume":"50","author":"Gao","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/02713683.2018.1426102","article-title":"YC-1 inhibits VEGF and inflammatory mediators expression on experimental central retinal vein occlusion in rhesus monkey","volume":"43","author":"Yan","year":"2018","journal-title":"Curr Eye Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:03:42Z","timestamp":1746331422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028283"}},"subtitle":["A protocol for systematic review and network meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":18,"journal-issue":{"issue":"52","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028283","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"assertion":[{"value":"2021-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}